HomeGTHX • NASDAQ
add
G1 Therapeutics Inc
Previous close
$4.98
Day range
$4.74 - $5.20
Year range
$1.08 - $6.14
Market cap
253.04M USD
Avg Volume
1.80M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 14.48M | 11.82% |
Operating expense | 22.44M | -39.72% |
Net income | -10.22M | 62.97% |
Net profit margin | -70.59 | 66.88% |
Earnings per share | -0.20 | 62.26% |
EBITDA | -8.93M | 65.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 65.19M | -43.96% |
Total assets | 102.03M | -37.00% |
Total liabilities | 74.29M | -36.49% |
Total equity | 27.74M | — |
Shares outstanding | 52.28M | — |
Price to book | 9.40 | — |
Return on assets | -20.24% | — |
Return on capital | -27.03% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -10.22M | 62.97% |
Cash from operations | -8.90M | 69.37% |
Cash from investing | 5.29M | 81.75% |
Cash from financing | -8.72M | -3,975.70% |
Net change in cash | -12.33M | 53.22% |
Free cash flow | -3.58M | 80.79% |
About
Founded
2008
Website
Employees
100